GaryScottMarshallMD

Pediatric Infectious Disease • Louisville, KY

Pediatric Vaccinology and Vaccine Preventable Diseases

Professor, Pediatrics, University of Louisville School of Medicine

Join to view full profile

Dr. Marshall is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Marshall's full profile

Already have an account?

Office
411 E Chestnut St
Louisville, KY 40202
Phone+1 502-588-2348

Fax+1 502-588-2334

Education & Training

Children's Hospital of PhiladelphiaFellowship, Pediatric Infectious Diseases, 1986 - 1989
Vanderbilt University Medical CenterResidency, Pediatrics, 1983 - 1986
Vanderbilt University School of MedicineClass of 1983
University of PennsylvaniaB.A., Summa Cum Laude, 1975 - 1979

Certifications & Licensure

IN State Medical License 2023 - 2025
KY State Medical License 1989 - 2025
PA State Medical License 1986 - 1990
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Infectious Diseases

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Top Three Peer Mentor Award (for “career-related or personal guidance that is highly valuable”) 2012
Distinguished Educator Award for “lifetime achievement of extraordinary success as a medical educator” University of Louisville School of Medicine, 2011
Kentucky Medical Educational Achievement Award for “outstanding contributions to the field of medical education” Kentucky Medical Association, 2011
Top Five Teaching Faculty of the Year (from the house staff “in honor of the excellence in clinical teaching, lecturing, and instruction”) 2011
Top Two Teaching Division of the Year (from the house staff “for excellence in clinical teaching, lecturing, and instruction”) 2010
Peer Clinician-Teacher Excellence Award for Established Faculty (from the pediatric faculty “for outstanding clinical and teaching services”) 2010
Outstanding Division Award (from the senior residents “for consistent excellence in patient care and resident teaching”) 2004-2005, 2009-2010, 2012, 2014
Educator of the Year Award (from the Department of Pediatrics “in recognition of outstanding teaching”) 2002
Nominated for the Trustees Award ("for faculty who have made an extraordinary impact on students", viewed as the highest award that can be given to a University of Louisville faculty member) 2000-2001
James R. Petersdorf Community Trust Fund Award for outstanding achievements in research Norton Healthcare, 1994
Second Place Award; Midwest Student Medical Research Forum Creighton University, 1993
President’s Young Investigator Award (from the President of the University of Louisville “for excellence in research and scholarship”) University of Louisville School of Medicine, 1992
Outstanding Clinical Professor Award (from the senior residents “for dedication to the art of pediatrics and commitment to the education of the house staff”) University of Louisville School of Medicine and Kosair Children’s Hospital, 1992
Fourth Place Award, 33rd Annual National Student Research Forum University of Texas Medical Branch, 1992
First Place Award, Midwest Student Medical Research Forum Creighton University, 1991
Fellow American Academy of Pediatrics, 1987
Fellow Pediatric Infectious Diseases Society, 1987
David T. Karzon Award (“Presented to the Resident Best Exemplifying Doctor Karzon’s Natural Curiosity, Love of Science, and Dedication to Research”) Vanderbilt University School of Medicine, 1986
Phi Beta Kappa University of Pennsylvania, 1978
Franklin Scholar Prize for Original Research University of Pennsylvania, 1977
Benjamin Franklin Scholar University of Pennsylvania, 1976
First Place Award for Overall Excellence in Research Sigma Xi
Top MD Consumers Checkbook
Join now to see all

Publications & Presentations

PubMed

Past, present, and future policy considerations regarding meningococcal vaccination in the United States.
Diana E Clements, Tosin Olaiya, Cindy Burman, Oscar Herrera-Restrepo, Woo-Yun Sohn
Expert Review of Vaccines. 2024-09-11
6 citations
A comprehensive review of clinical and real-world safety data for the four-component serogroup B meningococcal vaccine (4CMenB).
Gary S Marshall, Victoria Abbing-Karahagopian, Helen S Marshall, Silvia Cenci, James H Conway
Expert Review of Vaccines. 2023-06-06
Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years ...
Gary S Marshall, Stephen I Pelton, Corwin A Robertson, Philipp Oster
Human Vaccines & Immunotherapeutics. 2022-11-30

Journal Articles

Dismissal Policies for Vaccine Refusal
Gary Marshall, MD, JAMA
Characteristics of patients referred to a pediatric infectious diseases clinic with unexplained fever
Statler VA, Marshall GS, J Pediatr Infect Dis Soc, 1/1/2015
Safety and immunogenicity of tetanus-diphtheria-acellular pertussis vaccine administered to children 10 or 11 years of age
Marshall GS, Pool V, Greenberg DP, Johnson DR, Sheng X, Decker MD, Clin Vac Immunol, 1/1/2014
Prolonged and recurrent fevers in children
Marshall GS, J Infect, 1/1/2014
Hemophagocytic lymphohistiocytosis induced by monocytic ehrlichiosis
Statler VA, Marshall GS, J Pediatr, 1/1/2014
Cerebellitis and acute obstructive hydrocephalus associated with Mycoplasma pneumoniae infection
Schmucker RD, Ehret A, Marshall GS, Pediatr Infect Dis J, 1/1/2014
Steve Jobs wrestles with the electronic health record
Marshall GS, JAMA Pediatrics, 1/1/2013
Factors associated with receipt of two doses of varicella vaccine among adolescents in the United States
Kawai K, O’Brien MA, Conway JH, Marshall GS, Kuter BJ, Pediatr Infect Dis J, 1/1/2013
Antibodies persist for up to 5 years after a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccin...
Marshall GS, Blatter M, Aris E, Mesaros N, Miller JM, Pediatr Infect Dis J, 1/1/2013
Roots of vaccine hesitancy
Marshall GS, South Dakota Med, 1/1/2013
Immunogenicity and safety of measles–mumps–rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis...
Bryant KA, McVernon J, Marchant CD, Nolan T, Marshall GS, Richmond P, Marshall H, Nissen M, Lambert SB, Aris E, Mesaros N, Miller JM, Hum Vacc Immunother, 1/1/2012
The burden of infant meningococcal disease in the United States
Judelsohn R, Marshall GS, J Pediatr Infect Dis Soc, 1/1/2012
Common variable immunodeficiency presenting with persistent parvovirus B19 infection
Adams STM, Schmidt KM, Cost KM, Marshall GS, Pediatrics, 1/1/2012
A novel combined H influenzae type b–N meningitidis serogroups C and Y tetanus toxoid conjugate vaccine for infants and toddlers
Bryant KA, Marshall GS, Expert Rev Vaccines, 1/1/2011
Co-administration of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the i...
Marshall GS, Marchant CD, Blatter M, Friedland LR, Aris E, Miller JM, Human Vaccines, 1/1/2011
Pimping Protection for the 21st Century
Marshall GS, Louisville Medicine, 1/1/2011
A statement regarding personal belief exemption from immunization mandates
Vaccine Advocacy Committee of the Pediatric Infectious Diseases Society (Marshall GS), Pediatr Infect Dis J, 1/1/2011
Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine coadministered with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis ...
Wheeler CM, Harvey BM, Pichichero ME, Simon MW, Combs SP, Blatter MM, Marshall GS, Catteau G, Dobbelaere K, Descamps D, Dubin G, Schuind A, Pediatr Infect Dis J, 1/1/2011
Immunogenicity and safety of H influenza type b-N meningitidis C/Y conjugate vaccine in infants
Bryant KA, Marshall GS, Marchant CD, Pavia-Ruz N, Nolan T, Rinderknecht S, Blatter M, Aris E, Lestrate P, Boutriau D, Friedland LR, Miller JM, Pediatrics, 1/1/2011
Immunogenicity and safety of MMRV and PCV-7 administered concomitantly in healthy children
Leonardi M, Bromberg K, Baxter R, Gardner JL, Klopfer S, Nicholson O, Brockley M, Trammel J, Leamy V, Williams W, Kuter B, Schodel F (ProQuad Protocol 019 Study Team), Pediatrics, 1/1/2011
Immunogenicity and safety of a combined diphtheria, tetanus, 5-component acellular pertussis, inactivated poliomyelitis, Haemophilus type b conjugate vaccine when admi...
Bernstein HH, Noriega F, M5A07 Pentacel Study Group, Vaccine, 1/1/2011
Immune response and one-year antibody persistence after a fourth dose of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus to...
Marshall GS, Marchant CD, Blatter M, Aris E, Boutriau D, Poolman JT, Friedland LR, Miller JM, Pediatr Infect Dis J, 1/1/2010
Parental vaccine concerns in Kentucky
Smith MJ, Woods CR, Marshall GS+, J Kentucky Med Assoc, 1/1/2009
Use of standardized patients to examine physicians' communication strategies when addressing vaccine refusal: a pilot study
Bryant KA, Wesley GC, Wood JA, Hines C, Marshall GS+, Vaccine, 1/1/2009
Combination vaccine use and vaccination quality in a managed care population
Happe LE, Lunacsek OE, Marshall GS, Lewis T, Spencer S, Amer J Manag Care, 1/1/2007
Join now to see all

Books/Book Chapters

The Vaccine Handbook: A Practical Guide for Clinicians
Marshall GSProfessional Communications, Inc., West Islip, NYEdition 5th,2015
Principles and Practice of Pediatric Infectious Diseases
Chapter: Chronic Fatigue Syndrome
Page 1007 - 1015Marshall GS, Carter BDEditors: Long SS, Pickering LK, Prober CG.Churchill Livingstone, New York, NYEdition 4th,2012
The Vaccine Handbook: A Practical Guide for Clinicians
Marshall GSProfessional Communications, Inc., West Islip, NYEdition 4th,2012
The Vaccine Handbook: A Practical Guide for Clinicians
Marshall GSProfessional Communications, Inc., West Islip, NYEdition 3rd,2010
The Vaccine Handbook: A Practical Guide for Clinicians
Marshall GSProfessional Communications, Inc., West Islip, NYEdition 2nd,2008
The Vaccine Handbook: A Practical Guide for Clinicians.
Marshall GS (contributing authors: Penelope H. Dennehy, David P. Greenberg, Paul A. Offit, Tina Q. Tan)Lippincott Williams & Wilkins, Philadelphia, PA2003
Current Problems in Pediatrics
Chapter: New Developments: Diagnosis and Management of Chronic Fatigue in Children and Adolescents
Page 281 - 293Carter BD, Marshall GSEditors: Winter RJ.Mosby-Year Book, St. Louis, MO1995
Molecular Aspects of Human Cytomegalovirus Diseases
Chapter: Vaccine Strategies for the Prevention of Cytomegalovirus Disease
Page 283 - 300Marshall GS, Plotkin SAEditors: Huang E-S, Becker Y.Springer-Verlag, Berlin, Germany1993
Current Therapy in Pediatric Infectious Disease
Chapter: Chronic Fatigue Syndrome
Page 302 - 306Marshall GSEditors: Kaplan S.Mosby-Year Book, St. Louis, MO1993
The Human Herpesviruses
Chapter: Cytomegalovirus Vaccines
Page 381 - 395Marshall GS, Plotkin SAEditors: Lopez C, Whitley R, Roizman B.Raven Press, New York, NY1993
Pediatric Primary Care: A Problem-Oriented Approach
Chapter: Acquired Immune Deficiency Syndrome
Page 541 - 554Marshall GSEditors: Schwartz MW.Year Book Medical Publishers, Chicago, IL1990
Join now to see all

Abstracts/Posters

Immunogenicity and safety of an investigational hexavalent vaccine against diphtheria, tetanus, pertussis (DTaP5), polio (IPV), Haemophilus influenzae type b (Hib; PRP...
Block SL, Marshall GS+, Petrecz M, Flores S, Ngai A, Xu J, Foglia G, Lee AW, Protocol 005 and Protocol 006 Study Teams, American Academy of Pediatrics National Conference & Exhibition, Washington, DC, 1/1/2015
Management of complicated para-pneumonic effusion and empyema with initial parenteral antibiotics and early switch to oral equivalent.
Espinosa CM, Woods C, Marshall GS, 52nd Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 1/1/2014
Characteristics of patients referred to a pediatric infectious diseases clinic with unexplained fever.
Statler VA, Marshall GS, 52nd Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 1/1/2014
A phase III study of the safety, tolerability and immunogenicity of an investigational combination vaccine against diphtheria, tetanus, pertussis (DTaP5), polio (IPV),...
Marshall GS, Adams GL, Leonardi M, Petrecz M, Flores SA, Ngai AL, Xu J, Foglia G, Lee AW, Protocol 005 Study Team, 52nd Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 1/1/2014
Vaccine coverage at milestone ages among infants in the United States, 2009-2012.
Gebremeskel B, Zhang D, Goveia MG, Marshall GS, O’Brien MA, 52nd Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 1/1/2014
Factors associated with receipt of 2 doses of varicella vaccine among adolescents in the United States.
Kawai K, O'Brien MA, Conway JH, Marshall GS, Kuter BJ, 50th Annual Meeting of the Infectious Diseases Society of America, San Diego, CA, 1/1/2012
Antibody persistence 5 years after the fourth dose of an investigational Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y tetanus toxoid (Hi...
Marshall GS, Mesaros N, Aris E, Miller JM, 50th Annual Meeting of the Infectious Diseases Society of America, San Diego, CA, 1/1/2012
Persistence of immunity three years after receipt of an investigational Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y conjugate vaccine (...
Marshall GS, Mesaros N, Aris E, Marchant CD, Blatter M, Miller JM, 45th Annual National Immunization Conference, Washington, DC, 1/1/2011
Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y tetanus toxoid conjugate vaccine (HibMenCY) was immunogenic and safe in 6414 infants.
Bryant KA, Marshall GS, Marchant CD, Pavia-Ruz N, Nolan T, Rinderknecht S, Blatter M, Aris E, Boutriau D, Mesaros N, Friedland LR, Miller JM, 44th Annual National Immunization Conference, Atlanta, GA, 1/1/2010
Immune response to measles, mumps, rubella (MMR) and varicella (V) vaccine coadministered with a fourth dose of Haemophilus influenzae type b-Neisseria meningitidis se...
Bryant KA, McVernon J, Marchant CD, Nolan T, Marshall GS, Richmond P, Marshall H, Alexander K, Aris E, Mesaros N, Miller JM, Pediatric Academic Societies Meeting, Vancouver, British Columbia, Canada, 1/1/2010
Persistence of immunity 1 year after 4 doses of an investigational H. influenzae type b (Hib) and N. meningitides serogroups C and Y conjugate vaccine.
Marshall G, Marchant C, Blatter M, Aris E, Friedland L, Miller J, 47th Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 1/1/2009
Human papillomavirus (HPV)-16/18 ASO4-adjuvanted vaccine co-administered with other vaccines in female adolescents.
Wheeler CM, HPV-018 Study Group, 47th Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 1/1/2009
An investigational H. influenzae type b–N. meningitides serogroups C & Y tetanus toxoid conjugate vaccine (HibMenCY) is highly immunogenic and well tolerated in infants.
Bryant K, Marshall G, Marchant C, Ruiz P, Nolan T, Blatter M, Rinderknecht S, Boutriau D, Mesaros N, Friedland L, Miller J, 47th Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 1/1/2009
Parental vaccine concerns in Kentucky.
Smith MJ, Woods CR, Marshall GS, 43rd National Immunization Conference, Dallas, TX, 1/1/2009
Immunogenicity of a 7-valent pneumococcal conjugate vaccine co-administered with an investigational H. influenzae type b-N. meningitidis serogroups C & Y conjugate vac...
Miller J, Marshall G, Blatter M, Marchant C, Boutriau D, Friedland L, 46th Annual Meeting of the Infectious Diseases Society of America, Washington, DC, 1/1/2008
Immunity to an investigational H. influenzae type b-N. meningitidis serogroups C & Y conjugate vaccine measured in a serum bactericidal activity assay using human comp...
Miller J, Marshall G, Marchant C, Blatter M, Boutriau D, Friedland L, 46th Annual Meeting of the Infectious Diseases Society of America, Washington, DC, 1/1/2008
Use of standardized patients to examine private practice physicians' communication strategies when addressing vaccine refusal: Advantages and barriers to the research ...
Wesley GC, Bryant KA, Wood JA, Marshall GS, 12th International Ottawa Conference on Clinical Competence, New York, NY, 1/1/2006
Use of standardized mothers to study physician responses to vaccine refusal.
Bryant KA, Wesley GC, Wood JA, Hines CL, Marshall GS, Pediatric Academic Societies Meeting, San Francisco, CA, 1/1/2006
Coverage rates among children receiving combination versus component vaccines in a state Medicaid program.
Marshall GS, Happe LE, Russell A, 40th National Immunization Conference, Atlanta, GA, 1/1/2006
Impact of first-year DTaP doses on the timeliness of the fourth dose of DTaP among children in a state Medicaid population.
Marshall GS, Happe LE, Russell A, 40th National Immunization Conference, Atlanta, GA, 1/1/2006
Timeliness of childhood immunizations in a state Medicaid population.
Marshall GS, Happe LE, Russell A, 40th National Immunization Conference, Atlanta, GA, 1/1/2006
Incidence of intussusception with the pentavalent (human-bovine) reassortant rotavirus vaccine (PRV) is similar to placebo.
Vesikari T, Matson D, van Damme P, Heyse J, Dallas M, Goveia M, Black S, Shinefield H, Christie C, Rodriguez Z, Boslego J, Dennehy P, Marshall G, Gothefors L, Miller J..., 23rd Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID), Valencia, Spain, 1/1/2005
Clinical and laboratory features of Rocky Mountain spotted fever (RMSF) and human monocytic ehrlichiosis (HME) in children.
Buckingham SC, Marshall GS, Schutze GE, Woods CR, Jackson MA, Patterson LE, Jacobs RF, Pediatric Academic Societies Meeting, Washington, DC, 1/1/2005
Immunogenicity of tetanus-diphtheria-acellular pertussis (TdaP) vaccine in adolescents.
Daum R, Marshall G, Walter E, Bologa M, American Academy of Pediatrics 2004 National Conference and Exhibition, San Francisco, CA, 1/1/2004
Safety, tolerability, and immunogenicity of M-M-R™II with recombinant human albumin (rHA) evaluated in children 12 to 18 months of age.
Reisinger KS, Wiedmann RT, Sheaffer CI, Malacaman EA, Senders SD, Marchant CD, Protocol 009 Study Group for M-M-RII, Giacoletti KED, Shaw EE, Schodel FP, Musey LK, 42nd Annual Meeting of the Infectious Diseases Society of America, Boston, MA, 1/1/2004
Join now to see all

Lectures

Infectious and Noninfectious Causes of Recurrent and Periodic Fevers
National Conference & Exhibition 2019 - American Academy of Pediatrics - New Orleans, LA - 10/25/2019
Pediatrics for the Practitioner
Texas Health Science Center at San Antonio, San Antonio, TX - 1/7/2007
Invited testimony on meningococcal disease (HB 342, requiring colleges to educate freshmen about the risks of meningitis and the benefits of immunization) before the H...
Frankfort, KY - 1/26/2004
Pediatric Infectious Disease Update
University of South Carolina Beaufort, Hilton Head, SC - 1/14/2004
A Review of Developmental/Behavioral Disorders and A Spectrum of Pediatric Challenges
Hackensack University Medical Center and the Joseph M. Sanzari Children's Hospital, Hilton Head, SC - 1/22/2003
Invited testimony on vaccine safety before the Interim Joint Committee on Health and Welfare Families and Children Subcommittee
Frankfort, KY - 1/19/2003
Tick-Borne Diseases in Children
Steamboat Springs, CO - 1/16/2003
Immunizations: A Disease-Free Future for Families
Kansas City. MO - 1/13/2003
Update on Issues and Challenges in Pediatric Immunization
Wayne State University School of Medicine and Children’s Hospital of Michigan, Detroit, MI - 1/29/2002
Pediatric Infectious Disease: A Practical Approach to Current Issues
Indiana University School of Medicine, Indianapolis, IN - 1/13/2002
PREP:ID, A Comprehensive Review and Update of Pediatric Infectious Diseases
Chicago, IL - 1/15/2001
Chronic Fatigue Syndrome in Adolescents: State of the Art Workshop.
Washington, DC - 1/28/1998
Focus on Pediatrics: Infectious Diseases
St. John’s Mercy Child Health Center, St. Louis, MO - 1/19/1995
The Surgeon General's Workshop on Children with HIV Infection and Their Families.
Children's Hospital of Philadelphia, Philadelphia, PA - 1/6/1987
Join now to see all

Other

State has mandate to protect children from disease.
Marshall GS, Louisville Courier Journal
1/5/2015
Measles. (Radio Interview)
Marshall GS, WAVE-3 News
Louisville, KY - 1/3/2015
Immunization against rotavirus acute gastroenteritis: nearly 10 years after. Immunization Updates 2015;1:13-18 (continuing medical education monograph)
Marshall GS, Vindico Medical Education
1/1/2015
Vaccines: The strongest defense against many deadly diseases-Here's why they're safe and important.
Marshall GS, Vital Signs
1/1/2012
The Risk of Not Vaccinating Children. (Radio Interview)
Marshall GS, WUWM-89.7 FM
Milwaukee, WI - 1/18/2011
Investigational Hexavalent Combination Vaccine. (Radio Interview)
Marshall GS, WAVE-3 News
Louisville, KY - 1/18/2011
Importance of Vaccines. (Television Interview)
Marshall GS, WPGA (Mix in the Morning)
Macon, GA - 1/15/2011
Phase III Study of a New Pediatric Combination Vaccine. (Radio Interview)
Marshall GS, WKY Public Radio
Louisville, KY - 1/12/2011
Vaccines and autism. (Radio Interview)
Marshall GS, WHAS-11 News
Louisville, KY - 1/6/2011
Vaccines and autism. (Radio Interview)
Marshall GS, WAVE-3 News
Louisville, KY - 1/6/2011
Rotavirus prevention: Taking every opportunity to reduce the burden of disease. Continuing medical education monograph
Dennehy P, Marshall GS, Boston University School of Medicine and Haymarket Medical Education
1/1/2011
Addressing Parents’ Concerns About Vaccines. Continuing nursing education DVD (NurseTIP—Immunization Training for Nurses)
Marshall GS, University at Albany School of Public Health, Center for Public Health
1/1/2011
Vaccinology 101. Continuing nursing education DVD (NurseTIP—Immunization Training for Nurses)
Marshall GS, University at Albany School of Public Health, Center for Public Health
1/1/2011
Three-part monograph on vaccine coverage: 1) Why Vaccination Timeliness Matters; 2) The Impact of Combination Vaccines on Improved Timeliness and Coverage; 3) Overcomi...
Pelton SI, Bernardi PG, Block SL, Marshall GS, Middleton DB, Stevenson AM, PRI Healthcare Solutions
New York, NY - 1/1/2011
Vaccine safety. (Radio Interview)
Marshall GS, WKLY-32 News
Louisville, KY - 1/31/2009
The greatest risk is in not vaccinating kids.
Marshall GS, Milwaukee Wisconsin Journal Sentinel
http://www.jsonline.com/news/opinion/64620527.html
1/17/2009
Improving the quality of immunization care with combination vaccines. In: Pediatric Immunization: Meeting the Challenges of the 21st Century. Belshe RB, ed. Continuing...
Marshall GS, Vindico Medical Education
http://www.pediatricsupersite.com/view.aspx?rid=43451
1/1/2009
Rotavirus: Providing optimal protection to overcome genetic diversity. Continuing medical education monograph
Marshall GS, Matson DO, Staat MA, Dennehy P, Vindico Medical Education
1/1/2009
Pediatric Infectious Diseases in Children Aged 0-6 Years: Rationale for Early Immunization, Booster and Seroprotective Doses. Continuing medical education DVD
Marshall GS, Conway JH, Pelton S, Boston University School of Medicine and Med Learning Group
1/1/2009
Rotavirus Vaccine (Radio Interview)
Marshall GS, WAVE-3 News
Louisville, KY - 1/5/2008
A Comprehensive Overview of Rotavirus: Understanding Virology and Epidemiology to Effectively Manage and Prevent Disease. Continuing medical education DVD
Marshall GS, Dennehy PH, Staat MA, Postgraduate Institute for Medicine and Med Learning Group
1/1/2008
Rotavirus: Prevention and vaccination strategies to address burden of disease. Continuing medical education monograph
Marshall GS, Staat MA, Matson DO, Dennehy P, Vindico Medical Education
1/1/2008
Vaccines (Radio Interview)
Marshall GS, WDRB-Fox41 News
Louisville, KY - 1/1/2007
Rotavirus Gastroenteritis: Why Should We Care? Educational DVD and monograph
Marshall GS, Merck Vaccine Division
1/1/2006
Testing new rotavirus vaccines: Efficacy and safety. Continuing medical education monograph
Marshall GS, The Management and Prevention of Rotavirus
1/1/2006
Join now to see all

Press Mentions

NIH Launches Study on Long COVID-19 in ChildrenJuly 20th, 2021
'We Wrote History': How Kentucky Researchers and Volunteers Helped COVID Vaccine TrialsJune 23rd, 2021
Norton’s Pfizer COVID-19 Vaccine Trial for Children 6 Months to 11 Years Old UnderwayJune 18th, 2021
Join now to see all